CTC BIO, INC.
14Patents
13Active
14Granted
44Portfolio score
Filing activity: Jun 20, 2001 → Sep 11, 2020 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6984406B2 | Bacillus sp. WL-1 strain producing mannanase | Chemistry; Metallurgy | 5 | Expired |
| US8633176B2 | Pharmaceutical formulation containing choline alfoscerate | Human Necessities | 3 | Active |
| US9504721B2 | Bacteriophage and its use for preventing proliferation of pathogenic bacteria | Chemistry; Metallurgy | 3 | Active |
| US11116769B2 | Tadalafil free base-containing film dosage form containing polyethylene glycol-based polymer and/or vinyl pyrrolidone-based polymer as dispersion stabilizer | Human Necessities | 1 | Active |
| US9907759B2 | Sildenafil-free base-containing film preparation and method for producing same | Human Necessities | 1 | Active |
| US10045944B2 | Pharmaceutical composition containing clomipramine and preparation method therefor | Human Necessities | 1 | Active |
| US9492446B2 | Manufacturing method of solid dispersion containing itraconazole | Human Necessities | 0 | Active |
| US10512610B2 | Pharmaceutical composition containing clomipramine and preparation method therefor | Human Necessities | 0 | Active |
| US10004769B2 | Lactobacillus brevis G-101 strain and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10213437B2 | Pharmaceutical preparation for masked taste oral administration, containing clomipramine | Human Necessities | 0 | Active |
| US10045993B2 | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | Human Necessities | 0 | Active |
| US9339511B2 | Pharmaceutical formulation containing choline alfoscerate | Human Necessities | 0 | Active |
| US8343555B2 | Composition and method for treating or preventing white spot syndrome virus | Human Necessities | 0 | Active |
| US11266658B2 | Preparation, comprising inclusion complex of varenicline or pharmaceutically acceptable salt thereof, for oral administration | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.